INTECH Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.01M Buy
37,384
+3,005
+9% +$658K 0.08% 212
2026
Q1
$6.5M Buy
34,379
+15,587
+83% +$2.72M 0.06% 276
2025
Q4
$3.19M Buy
18,792
+8,180
+77% +$1.25M 0.03% 523
2025
Q3
$1.4M Sell
10,612
-5,475
-34% -$657K 0.01% 989
2025
Q2
$1.71M Sell
16,087
-15,272
-49% -$1.66M 0.02% 866
2025
Q1
$3.89M Buy
31,359
+138
+0.4% +$18K 0.04% 412
2024
Q4
$3.84M Buy
31,221
+24,582
+370% +$2.9M 0.04% 416
2024
Q3
$740K Sell
6,639
-5,880
-47% -$644K 0.01% 991
2024
Q2
$1.34M Buy
+12,519
New +$1.38M 0.02% 551
2024
Q1
– Sell
-6,429
Closed -$791K – 706
2023
Q4
$791K Sell
6,429
-19
-0.3% -$2.37K 0.01% 467
2023
Q3
$835K Sell
6,448
-3,739
-37% -$498K 0.01% 473
2023
Q2
$1.26M Buy
10,187
+6,381
+168% +$859K 0.01% 427
2023
Q1
$557K Sell
3,806
-201
-5% -$29.7K ﹤0.01% 599
2022
Q4
$638K Buy
4,007
+201
+5% +$29.5K ﹤0.01% 581
2022
Q3
$507K Hold
3,806
– – ﹤0.01% 590
2022
Q2
$594K Buy
+3,806
New +$586K ﹤0.01% 589

Other funds holding JAZZ

INTECH Investment Management's JAZZ Position: Q2 2026 in Review

INTECH Investment Management increased its Jazz Pharmaceuticals (JAZZ) stake by 8.7% in Q2 2026, buying an estimated $658K and bringing the position to 37,384 shares worth $9.01M. The position accounts for 0.08% of the portfolio, ranked #212.

INTECH Investment Management first reported a position in JAZZ in Q2 2022 and has held it in 16 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • INTECH Investment Management held 37,384 shares of Jazz Pharmaceuticals worth $9.01M as of Q2 2026.
  • INTECH Investment Management bought 3,005 Jazz Pharmaceuticals shares in Q2 2026, an estimated $658K.
  • Jazz Pharmaceuticals made up 0.08% of INTECH Investment Management's portfolio in Q2 2026, its #212 holding.
  • INTECH Investment Management first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.